Interval cancers after negative immunochemical test compared to screen and non-responders’ detected cancers in Slovenian colorectal cancer screening programme
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. 10.1002/ijc.29210FerlayJSoerjomataramIDikshitREserSMathersCRebeloM.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 20122015136E3598610.1002/ijc.29210Open DOISearch in Google Scholar
Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-0008ZadnikVPrimic ZakeljMLokarKJarmKIvanusUZagarT.Cancer burden in Slovenia with the time trends analysis201751475510.1515/raon-2017-0008Open DOISearch in Google Scholar
Proposal for a Council Recommendation on Cancer Screening. Commission of the European Communities. 2003/0093(CNS). [cited 2018 Mar 15]. Available from: http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdfProposal for a Council Recommendation on Cancer ScreeningCommission of the European CommunitiesAvailable fromhttp://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdfSearch in Google Scholar
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71. 10.1056/NEJM199305133281901MandelJSBondJHChurchTRSnoverDCBradleyGMSchumanLMReducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study199332813657110.1056/NEJM199305133281901Open DOISearch in Google Scholar
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71. 10.1016/S0140-6736(96)03430-7KronborgOFengerCOlsenJJorgensenODSondergaardO.Randomised study of screening for colorectal cancer with faecal-occult-blood test199634814677110.1016/S0140-6736(96)03430-7Open DOISearch in Google Scholar
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7. 10.1016/S0140-6736(96)03386-7HardcastleJDChamberlainJORobinsonMHMossSMAmarSSBalfourTWRandomised controlled trial of faecal-occult-blood screening for colorectal cancer19963481472710.1016/S0140-6736(96)03386-7Open DOISearch in Google Scholar
Segnan N, Patnick J, von Karsa L, editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. First edition. European Commission. Luxembourg: Publications Office of the European Union; 2010 [cited 2018 Mar 15]. Available from: http://www.stopdarmkanker.be/BOEKJE/boekEU.pdfSegnanNPatnickJvon KarsaLEuropean Guidelines for Quality Assurance in Colorectal Cancer Screening and DiagnosisFirstLuxembourgPublications Office of the European Union2010cited 2018 Mar 15Available fromhttp://www.stopdarmkanker.be/BOEKJE/boekEU.pdfSearch in Google Scholar
Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011; 128: 3-11. 10.1002/ijc.25654DuffyMJvan RossumLGvan TurenhoutSTMalminiemiOSturgeonCLamerzRUse of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper201112831110.1002/ijc.2565420824704Open DOISearch in Google Scholar
Raffle A, Gray M. Screening: Evidence and Practice. Oxford: University Press; 2007.RaffleAGrayM.OxfordUniversity Press200710.1093/acprof:oso/9780199214495.001.0001Search in Google Scholar
Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 2015; 64: 1257-67. 10.1136/gutjnl-2014-307992SanduleanuSle ClercqCMDekkerEMeijerGARabeneckLRutterMDDefinition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature20156412576710.1136/gutjnl-2014-30799225193802Open DOISearch in Google Scholar
Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 6: 576-81. 10.1136/gutjnl-2011-300535SteeleRJMcClementsPWatlingCLibbyGWellerDBrewsterDHInterval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site201265768110.1136/gutjnl-2011-30053521930729Open DOISearch in Google Scholar
Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100: 259-65. 10.1038/sj.bjc.6604864GrazziniGVisioliCBZorziMCiattoSBanovichFBonanomiAGImmunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?20091002596510.1038/sj.bjc.6604864263471219142185Open DOISearch in Google Scholar
Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-9. 10.1136/gut.2010.223982ZorziMFedatoCGrazziniGStoccoFCBanovichFBortoliAHigh sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy201160944910.1136/gut.2010.223982Open DOISearch in Google Scholar
Tepeš B, Stefanovič M, Bračko M, Frković Grazio S, Maučec Zakotnik J, Novak Mlakar D, et al. [Slovenian colorectal cancer screening programme SVIT - results of pilot phase.] [Slovenian]. Zdrav Vestn 2010; 79: 403-11.TepešBStefanovičMBračkoMFrković GrazioSMaučec ZakotnikJNovak MlakarD[Slovenian colorectal cancer screening programme SVIT - results of pilot phase.] [Slovenian]20107940311Search in Google Scholar
Tepeš B, Bracko M, Novak Mlakar D, Stefanovic M, Stabuc B, Frkovic Grazio S, et al. Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia. J Clin Gastroenterol 2017; 51: e52-9. 10.1097/MCG.0000000000000662TepešBBrackoMNovak MlakarDStefanovicMStabucBFrkovic GrazioSResults of the FIT-based National Colorectal Cancer Screening Program in Slovenia201751e52910.1097/MCG.0000000000000662Open DOISearch in Google Scholar
Tepeš B, Kasesnik K, Novak Mlakar D, editos. [Slovenian guidelines of colorectal cancer screening programme SVIT: Slovenian guidelines ensure the quality of colorectal cancer screening.] [Slovenian]. First edition. Ljubljana: Nacionalni inštitut za javno zdravje; 2016.TepešBKasesnikKNovak MlakarDFirstLjubljanaNacionalni inštitut za javno zdravje2016Search in Google Scholar
International Classification of Diseases for Oncology, 3rd Edition. Geneva, Switzerland: World Health Organization; 2000.3rdGeneva, SwitzerlandWorld Health Organization2000Search in Google Scholar
Hakama M, Auvinen A, Day NE, Miller AB. Sensitivity in cancer screening. J Med Screen 2007; 14: 174-7. 10.1258/096914107782912077HakamaMAuvinenADayNEMillerAB.Sensitivity in cancer screening200714174710.1258/096914107782912077Open DOISearch in Google Scholar
Malila N, Oivanen T, Malminiemi O, Hakama M. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261. 10.1136/bmj.a2261MalilaNOivanenTMalminiemiOHakamaM.Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design2008337a226110.1136/bmj.a2261Open DOISearch in Google Scholar
GISCoR Working Group, Zorzi M (Coordinator). Detection of the interval cancers and estimate of the sensitivity of colorectal cancer screening programmes. Working report. Epidemiol Prev 2013; 37 (2-3 Suppl 1) [cited 2018 Mar 15]. Available from: http://www.epiprev.it/materiali/2013/EP2-3/S1_GISCOR/GISCOR_2013_Eng_def.pdfGISCoR Working Group, Zorzi M (Coordinator)Detection of the interval cancers and estimate of the sensitivity of colorectal cancer screening programmes. Working report2013372-3 Suppl 1cited 2018 Mar 15Available fromhttp://www.epiprev.it/materiali/2013/EP2-3/S1_GISCOR/GISCOR_2013_Eng_def.pdfSearch in Google Scholar
Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001; 92: 151-4. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.0.CO;2-6ZappaMCastiglioneGPaciEGrazziniGRubecaTTurcoPMeasuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience200192151410.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.0.CO26Open DOISearch in Google Scholar
van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, et al. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. Gastroenterology 2017; 153: 439-47. 10.1053/j.gastro.2017.05.004van der VlugtMGrobbeeEJBossuytPMMBosABongersESpijkerWInterval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing20171534394710.1053/j.gastro.2017.05.004Open DOISearch in Google Scholar
Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martínez-Indart L, World LB, et al. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain). J Gastroenterol 2017; 23: 2731-42. 10.3748/wjg.v23.i15.2731PortilloIArana-ArriEIdigorasIBilbaoIMartínez-IndartLWorldLBColorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)20172327314210.3748/wjg.v23.i15.2731540375228487610Open DOISearch in Google Scholar
Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation. Am J Gastroenterol 2010; 105: 188-98. 10.1038/ajg.2009.583SenoreCArmaroliPSilvaniMAndreoniBBisantiLMaraiLComparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation20101051889810.1038/ajg.2009.58319826409Open DOISearch in Google Scholar
Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, et al. Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain. Gastroenterol Res Pract 2015; 2015: 672410. Published online 2015 Feb 24. 10.1155/2015/672410GarciaMDomènechXVidalCTornéEMilàNBinefaGInterval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain20152015672410Published online 2015 Feb 2410.1155/2015/672410435471425802515Open DOISearch in Google Scholar
Steele RJ, Stanners G, Lang J, Brewster DH, Carey FA, Fraser CG. Interval cancers in a national colorectal cancer screening programme. United European Gastroenterol J 2016; 4: 587-94. 10.1177/2050640615624294SteeleRJStannersGLangJBrewsterDHCareyFAFraserCG.Interval cancers in a national colorectal cancer screening programme201645879410.1177/2050640615624294497179327536369Open DOISearch in Google Scholar
Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 757-64. 10.1038/bjc.2012.331MorrisEJAWhitehouseLEFarrellTNickersonCThomasJDQuirkePA retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme20121077576410.1038/bjc.2012.331342597422850549Open DOISearch in Google Scholar
Gill MD, Bramble MG, Rees CJ, Lee TJ, Bradburn DM, Mills SJ. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 417-21. 10.1038/bjc.2012.305GillMDBrambleMGReesCJLeeTJBradburnDMMillsSJ.Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme20121074172110.1038/bjc.2012.305340523022782347Open DOISearch in Google Scholar
Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H. Early detection of colorectal cancer with faecal occult blood test screening. Br J Surg 2010; 97: 1567-71. 10.1002/bjs.7150PaimelaHMalilaNPalvaTHakulinenTVertioHJärvinenH.Early detection of colorectal cancer with faecal occult blood test screening20109715677110.1002/bjs.715020603855Open DOISearch in Google Scholar
Barnett KN, Weller D, Smith S, Steele RJ, Vedsted P, Orbell S, et al. The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer. Health Expect 2018. 10.1111/hex.12672BarnettKNWellerDSmithSSteeleRJVedstedPOrbellSThe contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer201810.1111/hex.12672611749429457677Open DOISearch in Google Scholar
Digby J, Fraser CG, Carey FA, Lang J, Stanners G, Steele RJ. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited. J Med Screen 2016; 23: 130-4. 10.1177/0969141315609634DigbyJFraserCGCareyFALangJStannersGSteeleRJ.Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited201623130410.1177/096914131560963426589788Open DOISearch in Google Scholar